Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression
- 31 March 2005
- journal article
- research article
- Published by Elsevier BV in Neuropharmacology
- Vol. 48 (4), 492-502
- https://doi.org/10.1016/j.neuropharm.2004.11.015
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Aging and SB-269970-A, a selective 5-HT7 receptor antagonist, attenuate circadian phase advances induced by microinjections of serotonergic drugs in the hamster dorsal raphe nucleusBrain Research, 2004
- SB‐656104‐A, a novel selective 5‐HT7 receptor antagonist, modulates REM sleep in ratsBritish Journal of Pharmacology, 2003
- SB‐258741: A 5‐HT7 Receptor Antagonist of Potential Clinical InterestCNS Drug Reviews, 2002
- Localization of 5-HT7 receptors in rat brain by immunocytochemistry, in situ hybridization, and agonist stimulated cFos expressionJournal of Chemical Neuroanatomy, 2001
- A Novel, Potent, and Selective 5-HT7Antagonist: (R)-3-(2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970)Journal of Medicinal Chemistry, 2000
- Increased Vulnerability of NFH-LacZ Transgenic Mouse to Traumatic Brain Injury-Induced Behavioral Deficits and Cortical DamageJournal of Cerebral Blood Flow & Metabolism, 1999
- (R)-3,N-Dimethyl-N-[1-methyl-3-(4-methylpiperidin-1-yl)propyl]benzenesulfonamide: The First Selective 5-HT7Receptor AntagonistJournal of Medicinal Chemistry, 1998
- Assignment of the 5HT7 receptor gene (HTR7) to chromosome 10q and exclusion of genetic linkage with tourette syndromeGenomics, 1995
- Cloning and Expression of a 5‐Hydroxytryptamine7 Receptor Positively Coupled to Adenylyl CyclaseJournal of Neurochemistry, 1994
- Phase Advance of the Circadian Sleep-Wake Cycle as an AntidepressantScience, 1979